Voyager Therapeutics Inc. (VYGR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Voyager Therapeutics Inc.

NASDAQ: VYGR · Real-Time Price · USD
4.86
0.14 (2.97%)
At close: Oct 03, 2025, 3:59 PM
4.86
0.00%
After-hours: Oct 03, 2025, 06:46 PM EDT

Voyager Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
71.37M 68.8M 98.96M 117.43M
Short-Term Investments
195.32M 162.07M 19.89M 15.11M
Long-Term Investments
65.7M 1.59M 1.51M 1.78M
Other Long-Term Assets
2.87M n/a n/a n/a
Receivables
4.49M 84.45M 639K 748K
Inventory
n/a n/a 779K 1.71M
Other Current Assets
2.87M 2.63M 4.23M 1.7M
Total Current Assets
276.81M 319.68M 124.5M 136.7M
Property-Plant & Equipment
47.66M 30M 33.34M 55.38M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
116.24M 31.6M 34.86M 57.16M
Total Assets
393.05M 351.28M 159.36M 193.85M
Account Payables
4M 1.6M 2.57M 574K
Deferred Revenue
24.39M 42.88M 65.83M 42.1M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
6.75M 10.21M 3.26M 5.93M
Total Current Liabilities
49.79M 64.51M 72.59M 50.98M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1M 1M 1M 1M
Total Long-Term Liabilities
43.5M 50.45M 27.75M 47.82M
Total Liabilities
93.29M 114.96M 100.34M 98.8M
Total Debt
43.73M 20.29M 23.13M 44.18M
Book Value
299.76M 236.32M 59.02M 95.06M
Book Value Per Share
5.20 5.49 1.54 2.52
Common Stock
55K 44K 38K 38K
Retained Earnings
-326.18M -261.18M -393.51M -347.1M
Comprehensive Income
-407K -48K -219K -138K
Shareholders Equity
299.76M 236.32M 59.02M 95.06M
Total Investments
261.02M 163.67M 19.89M 15.11M